These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10649502)

  • 41. Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis.
    Griffey M; Bible E; Vogler C; Levy B; Gupta P; Cooper J; Sands MS
    Neurobiol Dis; 2004 Jul; 16(2):360-9. PubMed ID: 15193292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis.
    Hofmann SL; Lee LA; Lu JY; Verkruyse LA
    Neuropediatrics; 1997 Feb; 28(1):27-30. PubMed ID: 9151316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
    Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
    Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin.
    Siintola E; Topcu M; Kohlschütter A; Salonen T; Joensuu T; Anttonen AK; Lehesjoki AE
    Clin Genet; 2005 Aug; 68(2):167-73. PubMed ID: 15996215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infantile neuronal ceroid lipofuscinosis: follow-up on a Spanish series.
    Pérez Poyato MS; Milá Recansens M; Ferrer Abizanda I; Domingo Jiménez R; López Lafuente A; Cusí Sánchez V; Rodriguez-Revenga L; Coll Rosell MJ; Gort L; Póo Argüelles P; Pineda Marfa M
    Gene; 2012 May; 499(2):297-302. PubMed ID: 22387303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis.
    Hellsten E; Vesa J; Olkkonen VM; Jalanko A; Peltonen L
    EMBO J; 1996 Oct; 15(19):5240-5. PubMed ID: 8895569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis.
    de Vries BB; Kleijer WJ; Keulemans JL; Voznyi YV; Franken PF; Eurlings MC; Galjaard RJ; Losekoot M; Catsman-Berrevoets CE; Breuning MH; Taschner PE; van Diggelen OP
    Prenat Diagn; 1999 Jun; 19(6):559-62. PubMed ID: 10416973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variant late infantile neuronal ceroid lipofuscinosis (CLN6 gene) in Saudi Arabia.
    Al-Muhaizea MA; Al-Hassnan ZN; Chedrawi A
    Pediatr Neurol; 2009 Jul; 41(1):74-6. PubMed ID: 19520283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants.
    Voznyi YV; Keulemans JL; Mancini GM; Catsman-Berrevoets CE; Young E; Winchester B; Kleijer WJ; van Diggelen OP
    J Med Genet; 1999 Jun; 36(6):471-4. PubMed ID: 10874636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice.
    Virmani T; Gupta P; Liu X; Kavalali ET; Hofmann SL
    Neurobiol Dis; 2005 Nov; 20(2):314-23. PubMed ID: 16242638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.
    Topçu M; Tan H; Yalnizoğlu D; Usubütün A; Saatçi I; Aynaci M; Anlar B; Topaloğlu H; Turanli G; Köse G; Aysun S
    Turk J Pediatr; 2004; 46(1):1-10. PubMed ID: 15074367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase.
    Lu JY; Verkruyse LA; Hofmann SL
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10046-50. PubMed ID: 8816748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel c.776_777insA mutation in CLN1 leads to infantile neuronal ceroid lipofuscinosis.
    Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1106-11. PubMed ID: 23857568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomics insights into infantile neuronal ceroid lipofuscinosis (CLN1) point to the involvement of cilia pathology in the disease.
    Segal-Salto M; Hansson K; Sapir T; Kaplan A; Levy T; Schweizer M; Frotscher M; James P; Reiner O
    Hum Mol Genet; 2017 May; 26(9):1678. PubMed ID: 28334871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD).
    Hofman IL; Taschner PE
    Am J Med Genet; 1995 Jun; 57(2):165-7. PubMed ID: 7668323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).
    Eaton SL; Proudfoot C; Lillico SG; Skehel P; Kline RA; Hamer K; Rzechorzek NM; Clutton E; Gregson R; King T; O'Neill CA; Cooper JD; Thompson G; Whitelaw CB; Wishart TM
    Sci Rep; 2019 Jul; 9(1):9891. PubMed ID: 31289301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversible Cysteine Acylation Regulates the Activity of Human Palmitoyl-Protein Thioesterase 1 (PPT1).
    Segal-Salto M; Sapir T; Reiner O
    PLoS One; 2016; 11(1):e0146466. PubMed ID: 26731412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of Caenorhabditis elegans palmitoyl protein thioesterase1.
    Porter MY; Turmaine M; Mole SE
    J Neurosci Res; 2005 Mar; 79(6):836-48. PubMed ID: 15672447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1(R151X) mouse model of INCL.
    Thada V; Miller JN; Kovács AD; Pearce DA
    J Cell Mol Med; 2016 Feb; 20(2):381-5. PubMed ID: 26648046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.